Recombinant Streptococcus pneumoniae UPF0176 protein spr0084 (spr0084)

What is the UPF0176 protein family and how is spr0084 classified within it?

The UPF0176 designation refers to "Uncharacterized Protein Family 0176," indicating proteins with conserved sequences but incompletely characterized functions. Spr0084 is a member of this family found in Streptococcus pneumoniae and is classified as a hypothetical protein, suggesting its function has been computationally predicted but not experimentally validated . Understanding its placement within this family requires phylogenetic analysis comparing the amino acid sequence with other UPF0176 members across bacterial species to identify conserved domains and potential functional motifs.

What expression systems are most suitable for producing recombinant spr0084?

Multiple expression systems have been validated for spr0084 production, including bacterial (E. coli), yeast, baculovirus, and mammalian cell systems . The choice depends on research objectives:

For structural studies requiring high yields, E. coli systems typically suffice. For functional studies investigating protein-protein interactions, mammalian or baculovirus systems may preserve critical structural features .

How can I verify the purity and identity of recombinant spr0084?

Verification requires a multi-method approach:

• SDS-PAGE: Standard method establishing ≥85% purity for research-grade preparations

• Western blotting: Confirm identity using anti-His tag antibodies (if His-tagged) or custom antibodies against spr0084

• Mass spectrometry: Peptide mass fingerprinting to confirm sequence identity

• Size-exclusion chromatography: Assess homogeneity and oligomeric state

• N-terminal sequencing: Verify the first 5-10 amino acids match predicted sequence

For publication-quality data, combine at least three orthogonal methods to conclusively establish protein identity and purity.

What strategies can optimize soluble expression of spr0084 when facing inclusion body formation?

When confronting inclusion body challenges with spr0084 expression, implement a systematic optimization approach:

• Temperature modulation: Lower expression temperature to 16-20°C to slow protein synthesis and facilitate proper folding

• Induction optimization: Reduce IPTG concentration to 0.1-0.5 mM and extend expression time

• Co-expression strategies: Introduce molecular chaperones (GroEL/GroES, DnaK/DnaJ) on compatible plasmids

• Fusion tag screening: Test multiple solubility-enhancing tags:

  • MBP (maltose-binding protein)

  • SUMO

  • Thioredoxin

  • GST (with caution as it may dimerize)

• Buffer optimization during lysis: Include stabilizing additives like glycerol (10-20%), reducing agents, and appropriate salt concentrations

If inclusion bodies persist, implement a refolding protocol using gradual dialysis against decreasing concentrations of chaotropic agents while monitoring secondary structure recovery through circular dichroism .

How can I investigate potential functions of spr0084 given its "hypothetical" designation?

A systematic function-discovery workflow for spr0084 should include:

• Bioinformatic analysis:

  • Profile-sequence and profile-profile comparisons with characterized proteins

  • Structural prediction using AlphaFold2 or RoseTTAFold

  • Identification of conserved residues across pneumococcal strains

• Gene knockout/complementation studies:

  • Generate spr0084 deletion mutants in S. pneumoniae

  • Perform phenotypic characterization across growth conditions

  • Complement with wild-type and site-directed mutants

• Protein interaction mapping:

  • Pull-down assays using His-tagged spr0084

  • Bacterial two-hybrid screening

  • Cross-linking mass spectrometry to identify interacting partners

• Structural biology approach:

  • X-ray crystallography or cryo-EM to determine 3D structure

  • Compare with structural homologs for functional inference

This multi-faceted approach has successfully identified functions for other UPF proteins in bacterial systems and represents the gold standard for hypothetical protein characterization .

What is the optimal storage protocol for maintaining spr0084 stability and activity?

Long-term stability of spr0084 requires careful storage consideration:

• Avoid repeated freeze-thaw cycles, which can lead to protein aggregation and activity loss

• Store working aliquots at 4°C for maximum one week to maintain integrity

• For long-term storage, prepare single-use aliquots with 50% glycerol as cryoprotectant

• Store at -20°C/-80°C in buffer systems containing stabilizers:

  • Tris/PBS-based buffers (pH 8.0) with 6% trehalose provide optimal stability

  • Include reducing agents (1-5 mM DTT or β-mercaptoethanol) to prevent disulfide bond formation

  • Consider protein-specific stabilizers based on thermal shift assays

Research shows that lyophilized preparations exhibit extended shelf life (12 months) compared to liquid formulations (6 months) when stored at -20°C/-80°C .

How can I determine if spr0084 undergoes post-translational modifications in native S. pneumoniae?

Investigating native post-translational modifications (PTMs) requires:

• Isolation protocol:

  • Develop an immunoprecipitation strategy using antibodies raised against recombinant spr0084

  • Extract native protein under non-denaturing conditions to preserve modifications

  • Use protease inhibitors and modification-preserving buffers (phosphatase inhibitors, deacetylase inhibitors)

• Mass spectrometry workflow:

  • Perform intact protein MS to determine mass shifts from predicted values

  • Conduct bottom-up proteomics with multiple proteases for complete sequence coverage

  • Apply enrichment strategies for specific PTMs (TiO₂ for phosphorylation, lectin affinity for glycosylation)

• Comparative analysis:

  • Compare PTM profiles between recombinant and native protein

  • Assess PTM changes under different growth conditions or stress responses

  • Quantify stoichiometry of modifications at specific sites

This approach has revealed unexpected regulatory modifications in other "hypothetical" proteins, potentially linking them to bacterial stress responses and virulence mechanisms.

What approaches can determine if spr0084 contributes to S. pneumoniae virulence?

Investigating virulence contributions requires:

• Gene expression analysis:

  • Measure spr0084 expression during infection using qRT-PCR

  • Assess expression in different pneumococcal serotypes

  • Monitor regulation during host-pathogen interaction phases

• In vitro infection models:

  • Compare wild-type and spr0084 deletion mutants in:

    • Adherence to human respiratory epithelial cells

    • Biofilm formation capacity

    • Resistance to oxidative stress and neutrophil killing

• In vivo infection studies:

  • Mouse pneumonia and bacteremia models

  • Competitive index assays (wild-type vs. mutant)

  • Histopathological analysis of infected tissues

• Interactome mapping:

  • Identify host proteins that interact with spr0084

  • Characterize effects on host cellular pathways

This systematic approach has successfully identified virulence factors from other hypothetical proteins in pathogenic bacteria and provides a roadmap for spr0084 characterization in pneumococcal pathogenesis.

How can I develop reliable antibodies against spr0084 for immunolocalization studies?

Development of specific antibodies requires:

• Epitope selection:

  • Perform computational epitope prediction to identify surface-exposed regions

  • Select 2-3 peptide regions (15-20 amino acids) with high antigenicity scores

  • Avoid regions with sequence similarity to other pneumococcal proteins

• Immunization strategy:

  • Immunize rabbits with full-length recombinant protein (≥85% purity)

  • Alternatively, use KLH-conjugated synthetic peptides corresponding to predicted epitopes

  • Implement a standard 56-day immunization protocol with 4 booster injections

• Antibody validation:

  • Test specificity against recombinant protein via Western blot

  • Perform pre-adsorption controls with recombinant protein

  • Validate using pneumococcal lysates from wild-type and spr0084 knockout strains

  • Confirm specificity in immunofluorescence by comparing staining patterns

This methodological approach ensures antibodies suitable for subcellular localization studies, providing insight into spr0084's spatial distribution within the pneumococcal cell.

How should I design experiments to investigate potential enzymatic activity of spr0084?

When investigating unknown enzymatic functions:

• Substrate screening:

  • Perform in silico analysis for structural similarity to known enzymes

  • Screen against substrate libraries based on predicted function:

    • Generic substrates (p-nitrophenyl compounds)

    • Nucleotide processing (ATP, GTP hydrolysis)

    • Peptidase/protease activity (fluorogenic peptides)

    • Phosphatase activity (phosphorylated substrates)

• Assay development:

  • Optimize protein concentration, buffer conditions, and cofactor requirements

  • Establish positive and negative controls for each assay

  • Develop high-throughput screening methodology for efficient substrate identification

• Kinetic characterization:

  • Determine basic kinetic parameters (Km, Vmax, kcat)

  • Assess effects of pH, temperature, and ionic strength on activity

  • Identify potential inhibitors or activators

• Structure-function analysis:

  • Generate site-directed mutants of conserved residues

  • Correlate structural features with catalytic properties

This systematic approach has successfully identified novel enzymatic functions in previously uncharacterized bacterial proteins.

What are the critical considerations when interpreting protein-protein interaction data for spr0084?

Proper interpretation requires:

• Technical validation:

  • Confirm interactions using multiple orthogonal methods (Y2H, pull-down, FRET, SPR)

  • Quantify interaction strength (Kd values) using purified components

  • Validate direct interactions versus complex-mediated associations

• Biological validation:

  • Co-immunoprecipitation from pneumococcal lysates

  • Co-localization studies using fluorescence microscopy

  • Genetic evidence (synthetic lethality, suppressor mutations)

• Common artifacts to exclude:

  • Non-specific binding to tags or matrices

  • Interactions mediated by misfolded proteins

  • Co-purification of abundant proteins (ribosomal proteins, chaperones)

• Functional relevance assessment:

  • Map interaction domains through truncation analysis

  • Demonstrate phenotypic consequences of disrupting interactions

  • Place interactions in context of known cellular pathways

This rigorous interpretation framework prevents overinterpretation of technical artifacts while identifying biologically meaningful interactions for further characterization.

How can structural information about spr0084 guide functional studies?

Structural characterization provides critical insights:

• Structure determination approaches:

  • X-ray crystallography (requires 10-15 mg of highly pure protein)

  • Cryo-electron microscopy (for larger complexes)

  • NMR spectroscopy (for dynamic regions)

  • AlphaFold2 prediction as starting point

• Structure-guided analyses:

  • Identification of potential active sites through cavity analysis

  • Evolutionary conservation mapping onto structural elements

  • Electrostatic surface analysis for interaction interfaces

  • Molecular dynamics simulations to identify flexible regions

• Structure-based functional prediction:

  • Comparison with structural databases (DALI, VAST) to identify similar folds

  • Recognition of structural motifs associated with specific functions

  • Virtual screening of potential ligands or substrates

This structure-function integration approach has successfully annotated functions for numerous hypothetical proteins and represents the gold standard for mechanistic characterization of proteins like spr0084.

What is the recommended experimental workflow for investigating spr0084's role in pneumococcal physiology?

A comprehensive investigation requires:

• Initial characterization phase:

  • Generate knockout and conditional expression strains

  • Perform global phenotypic screening (Biolog, growth curves, stress responses)

  • Conduct transcriptome and proteome analysis of mutants versus wild-type

• Focused phenotypic analysis:

  • Based on initial screen results, develop targeted assays

  • Investigate potential roles in cell division, cell wall synthesis, or metabolism

  • Assess impact on antibiotic susceptibility and stress resistance

• Mechanistic investigation:

  • Determine subcellular localization

  • Identify interaction partners

  • Characterize biochemical activities

• Physiological context:

  • Define conditions regulating spr0084 expression

  • Map regulatory networks controlling expression

  • Place function within known pneumococcal cellular pathways

This systematic workflow allows efficient functional characterization while maintaining flexibility to follow unexpected phenotypes that may reveal novel biological roles.